Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 3.52 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 3.12 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 2.72 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 2.13 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 3.54 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 2.9 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 2.16 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 2.39 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 0.0 | BCD100322A01 | 3.38 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 0.5 | BCD100322A03 | 1.73 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 1.0 | BCD100322A07 | 2.79 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 2.0 | BCD100322A11 | 3.55 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 4.0 | BCD100322A15 | 3.8 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 8.0 | BCD100322A19 | 4.39 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 12.0 | BCD100322A23 | 3.75 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 24.0 | BCD100322A27 | 3.7 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 3.84 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 3.8 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 2.77 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 2.37 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 2.94 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 2.96 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 2.95 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 0.5 | BCD100322A04 | 3.93 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 1.0 | BCD100322A08 | 3.3 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 2.0 | BCD100322A12 | 3.59 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 4.0 | BCD100322A16 | 2.64 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 8.0 | BCD100322A20 | 3.54 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 12.0 | BCD100322A24 | 3.99 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 24.0 | BCD100322A28 | 3.05 | pmol/sample |